NEW YORK, Aug. 19 Reportlinker.com announces that a new market research report is available in its catalogue:
Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd ED
Advertisement
http://www.reportlinker.com/p0265199/Advances-in-Large-Scale-BioManufacturing-and-Scale-Up-Production-2nd-ED.html
A Comprehensive Study of the Science, Technology and Business of Biopharmaceutical Manufacturing. This new ASM study provides a clear view of what the industry perceives to be the future of biopharmaceutical manufacturing.
Advertisement
Chapter Abstracts Index:
Frontiers in Bioprocessing: 2007
The Science for Biogenerics: Are We There Already?
Maximizing Productivity in Biopharmaceutical Manufacturing
Increasing Performance of Mammalian Expression Platforms
Cell Line Engineering and Development: Case Studies
Design of Large-Scale Cell Culture Process
Challenges in Biopharmaceutical Scale-up to Production
Large-Scale Microbial Production Technology for Human Therapeutic Products
Microbiological Methods in Support of Manufacturing
Initial Protein Recovery Process
The Scaling Up of Fermentation and Primary Recovery Processes of Soluble Protein Antigens
Scale-up of Saccharomyces cerevisiae Fermentation
Good Automation Manufacturing Practice (GAMP)
Advances in Improved Expression of Recombinant Proteins in Microbial Systems
Design of Large-Scale Cell Culture Process --A Process Engineering Point of View
Protein Stability, Solubility and Solute Interactions
Launching New Biologics: A Process and Facility Design Approach
Disposable Technologies for Manufacturing of Biologics
Managing Large Volume, Single Use Disposables
Optimization of Antibody Processing: Upstream and Downstream
Simulated Moving Bed Chromatography
Implementation of Membrane Technology in Antibody Large-Scale Purification
Development of Viral Clearance Strategies for Large-Scale Monoclonal Antibody Production
Downstream Processing: Removing Economic and Technical Bottlenecks
Purification of Monoclonal and Genetically Engineered Antibodies
Regulatory Environment for Follow-on Biologics
Post-Approval Changes for Large Scale Biopharmaceutical Manufacturing: Global
FDA and Regulatory Issues in Biopharmaceutical Manufacturing
Strategic Issues: Capital Investments
Pricing Issues for Biotechnology Products
Economics of Scheduling, De-bottlenecking, and Cycle Time
Intellectual Property Considerations in Scale-Up of Biomanufacturing Processes
Forecasting Industry-wide Biopharmaceutical Manufacturing Capacity Requirements
Worldwide Therapeutic Protein Production Capacity
Authors and Reviewers:
Accelsiors Group International
Advanced Scientifics Inc.
Amgen, Inc.
Amgen, Inc.
Amgen, Inc.
Amgen, Inc.
Amgen, Inc.
Biogen IDEC
Biomanufacturing Training and Education Center
BioPharm Services UK
BioProcess Technology
Biotechnology Unit, NIDDK, NIH
Bristol Myers Squibb
Chromos, Burnaby, BC
Cambrex Bio Science
Clonex Development, Inc.
Consultants Inc.
Eli Lilly & Co.
Eli Lilly & Co.
Eli Lilly & Co.
Eli Lilly & Co.
Falconridge Associates
Fluor Corporation/Fluor Daniel Inc.
Fluor Corporation/Fluor Daniel Inc.
Fluor Corporation/Fluor Daniel Inc.
GE Healthcare
Human Genome Sciences
Institute for Chemical and Bioengineering
Intelligen, Inc.
Johns Hopkins University
Magneticals
Max Planck Institute
Medical Marketing Economics, LLC
Medimmune
Merck & Co., Inc.
Merck Research Laboratories
Merck Research Laboratories
Morphotek
NC State University
ncBIOsource
Newport Biotech Consultants
Newport Consulting
Novavax Inc
Novozymes Delta Limited
PD-Direct Services
Protein Sciences Corp
SAIC, National Cancer Institute
Sanofi Pasteur
Sartorius AG, Germany
Schwegman Lundberg Woessner & Kluth
Scios Inc.
Seattle Genetics
Strategic Manufacturing Worldwide, Inc.
TLG Consulting Inc.
Universite Clermont
Vectech Pharmaceutical Consultants, Inc.
To order this report:
Biopharmaceutical Industry: Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd ED
Biopharmaceutical Business News
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Contact Nicolas Bombourg: [email protected] US: (805)-652-2626 Intl: +1 805-652-2626
SOURCE Reportlinker
